Back to search results
NCT07601750

Local Anesthetic Clinical Trial

Enrolling by Invitation
PHASE4Ages 18–89InterventionalTreatment
Baylor Research Institute
~400 participants
Updated 2026-05-22 on ClinicalTrials.gov
What's tested:LidocaineBupivacaine HydrochlorideMepivacaine HydrochlorideChlorprocaine

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Determine if pain increases with local injections at each stage of surgery.
Measured over 5 mins, 15 mins, 20 mins, 25 mins, 30 mins, 45 mins (reconstruction)

Conditions

Mohs Micrographic Surgery
Anesthesia, Local

Explore related trials

Skin Neoplasm

Where it's being run

1 sites across 1 states
Texas1

Study leadership

  • Stan Tolkachjov, MD · PRINCIPAL_INVESTIGATOR · Baylor Scott and White Health

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

adults 18-89 years old
individuals with a cutaneous tumor treated by MMS

Exclusion

individuals younger than 18 and older than 89
pregnant individuals

What this trial measures

  • Determine if pain increases with local injections at each stage of surgery.5 mins, 15 mins, 20 mins, 25 mins, 30 mins, 45 mins (reconstruction)

    Assess changes in pain levels by determining if longer acting agents such as bupivacaine or bupivacaine with epinephrine will show lower reported pain scores by patients compared to shorter acting anesthetic agents such as lidocaine with epinephrine or mepivacaine when undergoing Mohs micrographic surgery. Patients will rate their pain verbally using the visual analog scale (VAS) of 1-10, where 1 is no pain and 10 is worst pain possible.